U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. Health Canada and FDA Joint Public Consultation on International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use - 10/19/2017
  1. News & Events for Human Drugs

Meeting | In Person

Event Title
Health Canada and FDA Joint Public Consultation on International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
October 19, 2017

Date:
October 19, 2017

The Food and Drug Administration (FDA) is announcing a regional public meeting entitled ‘‘Health Canada and United States Food and Drug Administration Joint Public Consultation on International Council for Harmonisation of Technical Requirements for Human Use (ICH)’’ to provide information and receive comments on the current activities of ICH as well as the upcoming meetings in Geneva, Switzerland, in November 2017. The topics to be discussed are the topics for discussion at the forthcoming ICH Assembly Meeting. The purpose of the public meeting is to solicit public input prior to the next ICH Assembly meeting and the expert working groups meetings in Geneva, Switzerland, scheduled for November 11 through 16, 2017, at which the discussion of the topics underway will continue.

Date:

October 19, 2017

Time:

9:00 a.m. to 12:00 p.m. ET

Location:

Sir Frederick G. Banting Research Centre
251 Sir Frederick Banting Driveway
Ottawa, ON K1Y 0M1, Canada

A website to access the webcast will be emailed to those who those who register  for the meeting as a remote attendee.

Registration:

If you wish to attend the public meeting either in-person or via webcast, please register at the following website: https://www.eventbrite.ca/e/health-canada-us-fda-consultation-on-ich-live-webcast-tickets-36514966247. Registrations may be limited, so early registration is recommended. Registration is free and will be on a first-come, first-served basis. However, the number of participants from each organization may be limited based on space limitations. Registrants will receive confirmation once they have been accepted.

Meeting Agenda

Contacts:

For more information: please contact Amanda Roache, amanda.roache@fda.hhs.gov

Back to Top